Bellicum Weighs Options After Hitting Brakes On CAR-T Program

 
• By Alaric DeArment
  
Bellicum is weighing options after announcing it would discontinue its two clinical CAR-T programs • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Strategy

More from Business